Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
New Life Pharma is a Thai pharmaceutical manufacturing company focused on commercial production and distribution of finished-dose medicines. The company markets a broad portfolio of generic and branded products across multiple dosage forms, including tablets, capsules, powders, creams, liquids, and suppositories. It operates manufacturing facilities in the Bangkok area, including separate production capabilities for penicillin and hormone products, and highlights Thai FDA GMP/GDP-compliant operations and PIC/S-oriented facility upgrades. In addition to manufacturing, the company maintains in-house research and development and serves pharmacies, hospitals, clinics, and export markets. Based on the available information, New Life Pharma appears to be a commercial-stage pharmaceutical manufacturer rather than a therapeutic biotech developer with a disclosed clinical pipeline.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on New Life.